Related Experiment Video
Updated: May 4, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
Hepatitis E: An emerging infection in high income countries
J E Arends1, V Ghisetti2, W Irving3
1Department of Internal Medicine and Infectious Diseases, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands; Members of the European Study Group on Viral Hepatitis (ESGVH) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Switzerland.
Hepatitis E virus (HEV) genotype 3 causes unexplained liver disease in Western countries. This review covers HEV GT3 virology, epidemiology, clinical aspects, and treatment in high-income nations.
Area of Science:
- Hepatology
- Virology
- Infectious Diseases
Background:
- Hepatitis E virus (HEV) genotype 3 is a significant cause of liver disease in Western countries.
- While often asymptomatic, HEV GT3 can lead to acute or chronic hepatitis, particularly in immunocompromised individuals.
- Extrahepatic manifestations of HEV GT3 infection are occasionally reported.
Purpose of the Study:
- To provide a comprehensive overview of Hepatitis E virus genotype 3.
- To discuss the virology, epidemiology, clinical presentation, and treatment of HEV GT3 infections.
- To highlight challenges in HEV GT3 diagnosis and management.
Main Methods:
- This is a review article, synthesizing existing knowledge on HEV GT3.
- Literature search on basic virology, epidemiology, clinical manifestations, and treatment strategies.
- Discussion of diagnostic methods, including limitations of antibody detection and advancements in molecular assays.
Main Results:
- HEV GT3 is an emerging cause of liver disease in high-income countries.
- Diagnostic accuracy of immunoassays for anti-HEV antibodies is moderate, especially in immunocompromised patients.
- A WHO international standard for HEV RNA detection by RT-PCR has been established.
Conclusions:
- HEV GT3 infections require increased recognition and understanding in clinical practice.
- Accurate diagnostics, including molecular methods, are crucial for managing HEV GT3.
- Further research and standardized diagnostic approaches are needed for effective HEV GT3 control.
Related Concept Videos
Viral Hepatitis I: Introduction
Hepatitis
Endocarditis I: Introduction
Infectious Diseases and Their Occurrence
Cirrhosis I: Introduction
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...

